Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling
📣 The data on this site is being moved. Please do not edit the data on this site yet. Thank you for your cooperation.